Multi-institutional phase II study of photodynamic therapy using ME2906 and PNL6405EPG for patients with local failure after chemoradiotherapy for esophageal cancer
Phase of Trial: Phase II
Latest Information Update: 12 Sep 2017
At a glance
- Drugs PNL6450EPG (Primary) ; Talaporfin (Primary)
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 06 Sep 2017 Status changed from active, no longer recruiting to completed.
- 16 Jan 2014 Status changed from recruiting to active, no longer recruiting, according to University Hospital Medical Information Network - Japan record.
- 28 Nov 2012 New trial record